C07D 499/86
Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a
Official title: with only atoms other than nitrogen atoms directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
C07D499/86 (Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a) appears on 14 US grants and 21 published applications in this corpus.
Search patents in C07D- Granted patents
- 14
- Published applications
- 21
- Assignees
- 16
- Inventors
- 57
- Latest grant
- 19 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 1 | 2 |
| 2007 | 0 | 1 |
| 2008 | 0 | 2 |
| 2009 | 1 | 2 |
| 2010 | 3 | 2 |
| 2011 | 0 | 0 |
| 2012 | 2 | 0 |
| 2013 | 2 | 1 |
| 2014 | 1 | 2 |
| 2015 | 0 | 2 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 1 | 0 |
| 2022 | 0 | 1 |
| 2023 | 1 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Broad spectrum anti-cancer compounds19 May 2026US 12,630,527 B2The Regents of the University of California
- Lactivicin compounds, their preparation and use as antibacterial agents10 Oct 2023US 11,780,832 B2Fedora Pharmaceuticals Inc.
- Crystalline beta-lactamase inhibitor21 Sep 2021US 11,124,526 B2Allecra Therapeutics SAS
- Tazobactam arginine compositions1 Apr 2014US 8,685,957 B1Cubist Pharmaceuticals, Inc.
- Beta-lactamase inhibitory compounds5 Nov 2013US 8,575,144 B2Southern Methodist University
- Methods for synthesizing deuterated formylindoles5 Jun 2025US 2025/0177538 A1Arizona Board of Regents on Behalf of the University of Arizona
- Broad spectrum anti-cancer compounds12 Oct 2023US 2023/0322715 A1The Regents of the University of California
- Lactivicin compounds, their preparation and use as antibacterial agents13 Oct 2022US 2022/0324858 A1Fedora Pharmaceuticals Inc.
- Crystalline beta-lactamase inhibitor7 Mar 2019US 2019/0071456 A1Allecra Therapeutics SAS
- Crystalline Beta-Lactamase Inhibitor6 Oct 2016US 2016/0289245 A1Allecra Therapeutics SAS
Most cited
By later US patents
- 6-(Aminoacyloxymethyl)penicillanic acid 1,1-dioxides as beta-lactamase inhibitors12US 4,503,040 APfizer Inc. · 1985
- Penam crystals and process for producing the same11US 7,547,777 B2Otsuka Chemical Co., Ltd. · 2009
- Tazobactam arginine compositions11US 8,476,425 B1Cubist Pharmaceuticals, Inc. · 2013
- Tazobactam arginine compositions5US 8,685,957 B1Cubist Pharmaceuticals, Inc. · 2014
- Bicyclic 6-alkylidene-penems as β-lactamase inhibitors3US 7,112,582 B2Wyeth · 2006